With the rise of AI, business leaders may be wondering: Is it time to outsource math to machines, freeing managers to do more managerial things? Harsha V. Misra is the founder of a private investment ...

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

The Gemini Deep Think mode announced at I/O 2025 is not here yet, but Google today is highlighting how it achieved a gold-medal level performance in a math, or maths, competition. The International ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

CML Microsystems PLC Annual stock financials by MarketWatch. View the latest CML financial statements, income statements and financial ratios.

Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people with a specific type of blood cancer get the best medicine for them. "The new ...

The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...

CML Microsystems (GB:CML) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...

Math can be a daunting, yet necessary, part of a student’s undergraduate curriculum. But the College of Science is stepping up to help students in first-year math courses succeed with the Saturday ...